Faculty profile

Peter Daley

ResearcherInfectious Diseases/Internal MedicineMemorial University of Newfoundland

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Memorial University of Newfoundland directory, so their courses may be missing. Find their university profile.

Peter Daley

Researcher

Infectious Diseases/Internal Medicine

Memorial University of Newfoundland

St. John's, Newfoundland and Labrador, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
23 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

377

Citations

101

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Trials Community Trial Sites Hepatitis C Virus Hiv/Aids Sexually Transmitted And Bloodborne Infections Training And Mentorship

Latest papers

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
New England Journal of Medicine · 2026
Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial
Trials · 2026
Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological study
Canadian Journal of Public Health · 2026

All 34 publications

Latest funding

Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform
CIHR · 2025 · Principal investigator
$2,015,775
CTN+ Phase 2 Atlantic Region Training and Mentorship. Activating New STBBI Trial Sites in Canada.
CIHR · 2025 · Nominated PI
$800,000
Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)
CIHR · 2024 · Co-investigator
$539,325

All 19 grants and awards

34 publications.

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Lee TC, Barina LA, Walls G, Goodman AL, Yahav D, Cheng MP, Bonten M, Bowen AC, Boyles T, Daneman N

New England Journal of Medicine202613 citations

DOI: 10.1056/nejmoa2506905

Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial

Prosty C, Carignan A, Chan AK, Chen Y, Daley P, Daneman N, Kandel C, Longtin Y, Perez-Patrigeon S, Wuerz T

Trials20261 citations

DOI: 10.1186/s13063-026-09883-1

Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological study

Lacroix M, Langford BJ, Chen C, Wang J, Tadrous M, Daneman N, Leung V, Gomes T, Friedman L, Daley P

Canadian Journal of Public Health2026

DOI: 10.17269/s41997-026-01189-8

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial

Armstrong E, Pinto R, Kulikova M, Yee NR, Rishu A, Muscedere J, Sibley S, Maslove DM, Boyd JG, Evans GA

Clinical Infectious Diseases2026

DOI: 10.1093/cid/ciag460

Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID).

Hosseini B, Condon A, da Costa BR, Daley P, Greiver M, Jüni P, Lee TC, McBrien K, McDonald EG, Murthy S, Selby P, Pinto AD

Contemporary clinical trials2026

DOI: 10.1016/j.cct.2026.108303 PMID: 41985658

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Butler CC, Pinto AD, Harris V, Holmes J, Rahman NM, Cureton L, Hayward G, Richards DB, Lowe DM, Standing JF, Breuer J, Hood K, Png ME, Petrou S, Dorward J, Patel MG, Thomas NPB, Evans P, Hart ND, Jani BD, Hosseini B, Murthy S, McBrien K, Condon A, McDonald EG, Daley P, Greiver M, da Costa BR, Selby P, Jüni P, Lee TC, Shi H, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Saville BR, Khoo SH, Nguyen-Van-Tam JS, Hobbs FDR, Yu LM, Little P, PANORAMIC Trial and CanTreatCOVID Trial Collaborative Groups

The New England journal of medicine2026

DOI: 10.1056/nejmoa2502457 PMID: 42019019

A qualitative scan on the challenges of AMR in Canada and experts' proposed solutions.

Lorcy A, Garnier A, Daley P, Dubé È

Canadian journal of microbiology2026

DOI: 10.1139/cjm-2025-0143 PMID: 41259775

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S

New England Journal of Medicine2025167 citations

DOI: 10.1056/nejmoa2404991

Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings

Hosseini B, Condon A, da Costa BR, Daley P, Greiver M, Jüni P, Lee TC, McBrien K, McDonald EG, Murthy S

BMJ Open20256 citations

DOI: 10.1136/bmjopen-2024-097134

Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia

Chen GS, Lee T, Tsang JLY, Binnie A, McCarthy A, Cowan J, Archambault P, Lellouche F, Turgeon AF, Yoon J

Critical Care Explorations20252 citations

DOI: 10.1097/cce.0000000000001262

Strategies for the Treatment and Prevention of Recurrent Clostridioides difficile infection: The SPORES Platform

Principal investigatorCIHR2025Project Grant

Principal investigators: McDonald, Emily G; Carignan, Alex; Chan, Adrienne; Chen, Yan; Daley, Peter; Daneman, Nick; Kandel, Christopher; Lee, Todd C; Longtin, Yves; Perez Patrigeon, Santiago; Wuerz, Terence

Keywords: C. Difficile; Clostridioides Difficile Infection; Diarrhea; Fidaxomicin; Nosocomial Infection; Placebo Controlled; Platform Trial; Randomized Controlled Trial; Recurrence; Vancomycin

$2,015,775

CTN+ Phase 2 Atlantic Region Training and Mentorship. Activating New STBBI Trial Sites in Canada.

Nominated PICIHR2025HIV/AIDS & STBBI Clinical Trials Research Network - Phase 2

Principal investigators: Daley, Peter; Masching, Renee; Barrett, Lisa; Chase, Brandyn; Kelly, Deborah V; Smyth, Daniel J; Webster, Duncan V

Keywords: Clinical Trials; Community Trial Sites; Hepatitis C Virus; Hiv/Aids; Sexually Transmitted And Bloodborne Infections; Training And Mentorship

$800,000

Clopidogrel vs. Aspirin in S. aureus Bacteremia (Clopido-SNAP)

Co-investigatorCIHR2024Project Grant

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawler, Patrick R; McDonald, Emily G; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Antithrombotic Therapy; Bacteremia; Randomized Controlled Trial; Staphylococcus Aureus

$539,325

Vancomycin dosing for serious MRSA infections: A non-inferiority randomized trial of trough level versus AUC/MIC.

Co-investigatorCIHR2024Project Grant

Principal investigators: Bai, Anthony D; Daneman, Nick; Jorgensen, Sarah C; Lee, Todd C; Loeb, Mark B; McDonald, Emily G; Mertz, Dominik; Morris, Andrew M

Keywords: Antibiotic Resistance; Antibiotic Therapy; Methicillin-Susceptible Staphylococcus Aureus (Mrsa); Vancomycin

$749,700

Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial

Co-investigatorCIHR2024Project Grant

Principal investigators: McDonald, Emily G; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawandi, Alexander; Lawler, Patrick R; Lee, Todd C; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve

Keywords: Adjunctive Therapies; Anticoagulants; Comparative Effectiveness Trial; Desirability Of Ordinal Outcomes Rating; Infectious Diseases; Nested Trials; Platform Trial; Pragmatic Trials; Staph Aureus Bacteremia

$539,325

A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)

Principal investigatorCIHR2024Project Grant

Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence

Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus

$1,705,952

Canadian antibiotic prescribing feedback initiative: Building a national framework to combat antimicrobial resistance in primary care (CANBuild-AMR)

Principal investigatorCIHR2023Op. Gr.: Eval. of pop.-level interv. to reduce AMR - Early Career Researcher

Principal investigators: Schwartz, Kevin L; Sheppard, Donald C; Bonnar, Paul; Burnes Achtymichuk, Laura; Daley, Peter; Ivers, Noah M; Légaré, France; Patrick, David M; Singer, Alexander G; Vanstone, Jason R

Keywords: Antibiotic Use; Antimicrobial Resistance; Antimicrobial Stewardship; Audit And Feedback; Evaluation; Implementation Science; Primary Care

$300,000

Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions

Co-investigatorCIHR2022Operating Grant: CNCCTN Extension - Indirect Costs

Principal investigators: Fowler, Robert A; Adhikari, Neill K; Archambault, Patrick; Bagshaw, Sean M; Binnie, Alexandra; Chasse, Michael; Cook, Deborah J; Daneman, Nick; Fiest, Kirsten M; Fox-Robichaud, Alison E; Goligher, Ewan C; Herridge, Margaret S; Kho, Michelle E; Lamontagne, Francois; Lawler, Patrick R; Lee, Todd C; Marshall, John C; McDonald, Emily G; McNally, James D; Meade, Maureen O; Mehta, Sangeeta; Menon, Kusum; Murthy, Srinivas; O'Hearn, Katharine J; Piquette, Dominique; Rochwerg, Bram N; Russell, James A; Tsang, Jennifer L; Turgeon, Alexis F; Wollny, Krista; Yada, Nicole; Zarychanski, Ryan

Keywords: Clinical Trials; Covid-19; Network

$1,000,000

Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence

Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia

$1,999,745

BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections

Co-investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna

Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial

$729,947

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Peter Daley

Research

Latest papers

Latest funding

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Secondary Prophylaxis of Recurrent Clostridioides difficile Infections During Systemic Antibiotics with Vancomycin (SPORES-V): study protocol for a randomized controlled trial

Evaluating equitable access based on sociodemographic predictors of nirmatrelvir-ritonavir use during the first year of availability in Ontario, Canada: A population-based ecological study

Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a sub-study of the BALANCE randomized clinical trial

Lessons learned and recommendations from the Canadian adaptive platform trial of treatments for COVID in community settings (CanTreatCOVID).

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

A qualitative scan on the challenges of AMR in Canada and experts' proposed solutions.

Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections

Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings

Machine Learning Accurately Predicts Need for Critical Care Support in Patients Admitted to Hospital for Community-Acquired Pneumonia

Frequent collaborators

Jennifer Tsang

Francois Lamontagne

Nick Daneman

Srinivas Murthy

Erick Duan

Robert Fowler

Ruxandra Pinto

Allison McGeer

Anne McCarthy

Juthaporn Cowan

Peter Selby

Kerry McBrien

Sylvain Lother

Michael Fralick

Michelle Greiver

Ryan Zarychanski

Michael Silverman

Haolun Shi

Ranjani Somayaji

John Conly

François Lellouche

Jennifer Grant

Patrick Archambault

Brendan Barrett

Daniel Warshafsky

Wendy Sligl

Rahim Moineddin

Jennifer Rayner

Rosemary Ricciardelli

Robert Wilson

Ian Ball

Karim Ali

Santiago Perez Patrigeon